Syndax Pharmaceuticals Inc.

(SNDX) Trade

By |

Profile

Syndax Pharmaceuticals Inc is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidate are entinostat which has direct effects on both cancer cells and immune regulatory cells, and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

Contact Information

Website: www.syndax.com
Email: ir@syndax.com
Main Phone: +1 781 419-1400
Address: 35 Gatehouse Drive
Address 2: Building D, Floor 3
State: MA
City / Town: Waltham
Country: USA
Postal Code: 02451

Issuer Information

Exchange: NGS
CEO: Briggs Morrison
Employees: 45
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 4.91 $ 0. (0.00%)
Last Price 4.91 Change $ 0. Change % 0.00 Tick N/A
Bid 4.64 Bid Size 100.00 Ask 5.02 Ask Size 100.00
Open N/A High N/A Low N/A Prev Close 4.91
Last Trade Volume 0 52 Wk Hi 15.20 52 Wk Low 4.36
Market Cap 121.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 24,835,951.00 EPS (TTM) -3.03 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 2 2
Number of Buys 1 1
Number of Sells 1 1
Net Activity 0 0
Last 10 Buys Shares
Ivor Royston 1,000
Last 10 Sell Shares
Peter Ordentlich 1,000
Peter Ordentlich 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 40 40 40 40
Low Target Price Estimate 20 20 20 20
Mean Target Price Estimate 27 27 27 27
Standard Deviation 8 8 8 8
Date of Most Recent Estimate 05/10/18 05/10/18 05/10/18 05/10/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 5 5 5
Moderate Buy 1 1 1 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.08 1.08 1.08 1.08